Jill Tate

1.2k total citations
34 papers, 906 citations indexed

About

Jill Tate is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Jill Tate has authored 34 papers receiving a total of 906 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Physiology. Recurrent topics in Jill Tate's work include Clinical Laboratory Practices and Quality Control (7 papers), Acute Myocardial Infarction Research (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Jill Tate is often cited by papers focused on Clinical Laboratory Practices and Quality Control (7 papers), Acute Myocardial Infarction Research (6 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers). Jill Tate collaborates with scholars based in Australia, United Kingdom and New Zealand. Jill Tate's co-authors include Greg Ward, Peter Mollee, Gus Koerbin, Peter E. Hickman, Carel Pretorius, Julia M. Potter, Stephen M. Sykes, Peter F. Nixon, Nicholas Glasgow and Jacobus Ungerer and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Clinical Chemistry.

In The Last Decade

Jill Tate

30 papers receiving 874 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jill Tate Australia 13 259 158 150 148 136 34 906
Davor Brinc Canada 19 282 1.1× 224 1.4× 337 2.2× 36 0.2× 340 2.5× 54 1.5k
Richard A. McPherson United States 20 347 1.3× 72 0.5× 125 0.8× 188 1.3× 261 1.9× 58 1.4k
A. Myron Johnson United States 16 143 0.6× 30 0.2× 167 1.1× 41 0.3× 253 1.9× 38 1.0k
Mira Barak Israel 19 155 0.6× 45 0.3× 88 0.6× 48 0.3× 124 0.9× 67 876
G H Kingsley United Kingdom 11 138 0.5× 121 0.8× 183 1.2× 42 0.3× 45 0.3× 16 945
Victor S. Sloan United States 14 227 0.9× 107 0.7× 76 0.5× 122 0.8× 68 0.5× 33 1.2k
Sabine Horn Austria 15 222 0.9× 135 0.9× 69 0.5× 67 0.5× 88 0.6× 43 915
Marc Thelen Netherlands 19 126 0.5× 43 0.3× 28 0.2× 51 0.3× 384 2.8× 65 920
Mario Veitl Austria 15 88 0.3× 52 0.3× 58 0.4× 47 0.3× 127 0.9× 21 632
Glen E. Cooke United States 15 156 0.6× 28 0.2× 105 0.7× 326 2.2× 98 0.7× 29 957

Countries citing papers authored by Jill Tate

Since Specialization
Citations

This map shows the geographic impact of Jill Tate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jill Tate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jill Tate more than expected).

Fields of papers citing papers by Jill Tate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jill Tate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jill Tate. The network helps show where Jill Tate may publish in the future.

Co-authorship network of co-authors of Jill Tate

This figure shows the co-authorship network connecting the top 25 collaborators of Jill Tate. A scholar is included among the top collaborators of Jill Tate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jill Tate. Jill Tate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lippi, Giuseppe, Philippe Gillery, Karl J. Lackner, et al.. (2017). Scientific publishing in the “predatory” era. Clinical Chemistry and Laboratory Medicine (CCLM). 56(5). 683–684. 3 indexed citations
2.
Kennard, Alice, Carmel M. Hawley, Jill Tate, et al.. (2015). Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis. Clinical Chemistry and Laboratory Medicine (CCLM). 54(6). 1045–52. 12 indexed citations
3.
Hickman, Peter E., Bertil Lindahl, Louise Cullen, et al.. (2014). Decision limits and the reporting of cardiac troponin: Meeting the needs of both the cardiologist and the ED physician. Critical Reviews in Clinical Laboratory Sciences. 52(1). 28–44. 10 indexed citations
4.
Klingberg, Sandra, et al.. (2014). Combined light chain immunofixation to detect monoclonal gammopathy: a comparison to standard electrophoresis in serum and urine. Clinical Chemistry and Laboratory Medicine (CCLM). 52(7). 981–7. 7 indexed citations
5.
Legg, Michael, et al.. (2014). Recommendations for reporting and flagging of reference limits on pathology reports.. PubMed. 35(4). 199–202. 5 indexed citations
6.
Koerbin, Gus, et al.. (2013). Evidence-based approach to harmonised reference intervals. Clinica Chimica Acta. 432. 99–107. 39 indexed citations
7.
Parsonage, William, Louise Cullen, Jaimi Greenslade, et al.. (2013). COMPARISON OF HIGHLY SENSITIVE TROPONIN I AND T RESULTS IN THE DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION. Journal of the American College of Cardiology. 61(10). E228–E228. 2 indexed citations
8.
Koerbin, Gus, Jill Tate, Julia M. Potter, et al.. (2012). Characterisation of a highly sensitive troponin I assay and its application to a cardio-healthy population. Clinical Chemistry and Laboratory Medicine (CCLM). 50(5). 871–8. 74 indexed citations
9.
Tate, Jill, Peter Mollee, James Daly, et al.. (2011). Analytical aspects of standardised protein electrophoresis and immunofixation reporting. Pathology. 43. S42–S42.
10.
Mollee, Peter, Jill Tate, Kirk Morris, et al.. (2010). Survival and prognostic factors amongst Australian patients with AL amyloidosis. Amyloid. 17. 150–151. 1 indexed citations
11.
Tirimacco, Rosy, Jill Tate, & Roger T. Johnson. (2010). Point-of-Care Testing.. PubMed. 31(3). 71–3. 1 indexed citations
12.
Tate, Jill, et al.. (2009). Quantitative serum free light chain assay--analytical issues.. PubMed. 30(3). 131–40. 55 indexed citations
13.
Tate, Jill. (2009). Serum free light chains. Pathology. 41. 17–17. 1 indexed citations
14.
Tate, Jill, et al.. (2009). Significance of abnormal protein bands in patients with multiple myeloma following autologous stem cell transplantation.. PubMed. 30(3). 113–8. 28 indexed citations
15.
Tate, Jill, et al.. (2008). Serum free light chain assay for diagnosis and monitoring of monoclonal light-chain diseases - Analytical and clinical correlations. Clinical Chemistry. 54(6). 1 indexed citations
16.
Hickman, Peter E., Gus Koerbin, Emma Southcott, et al.. (2007). Newer cardiac troponin I assays have similar performance to troponin T in patients with end-stage renal disease. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 44(3). 285–289. 31 indexed citations
17.
Morris, Kirk, Jill Tate, Devinder Gill, et al.. (2007). Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Internal Medicine Journal. 37(7). 456–463. 20 indexed citations
18.
Jones, Graham, et al.. (2004). The case for common reference intervals.. PubMed. 25(2). 99–104. 44 indexed citations
19.
Hickman, Peter E., Gus Koerbin, & Jill Tate. (2003). The reporting of cardiac troponin.. PubMed. 24(4). 99–108. 4 indexed citations
20.
Raud, Johan, et al.. (1998). [Blood sulfonamides in the rabbit and guinea pig after injection of sulfamethopyrazine and its acetylated derivative].. PubMed. 53. 352–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Davor Brinc Breakdown of academic impact, for papers by Richard A. McPherson Breakdown of academic impact, for papers by A. Myron Johnson Breakdown of academic impact, for papers by Mira Barak Breakdown of academic impact, for papers by G H Kingsley Breakdown of academic impact, for papers by Victor S. Sloan Breakdown of academic impact, for papers by Sabine Horn Breakdown of academic impact, for papers by Marc Thelen Breakdown of academic impact, for papers by Mario Veitl Breakdown of academic impact, for papers by Glen E. Cooke
Rankless by CCL
2026